semaglutide clearance in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Spotlight on the Mechanism of – Semaglutide Half-Life & System Clearance

Metformin users, common among type 2 diabetes patients who then add semaglutide, face a double hit since metformin independently reduces B12 absorption by 10-30% over long-term use

GLP-1 Receptors Exist Throughout the Body Although GLP-1 medications work in the pancreas to regulate insulin and glucagon, GLP-1 receptors are widely distributed in other areas of the body, including the brain, cardiovascular system, immune system, gut, and kidneys, says Diana Isaacs, PharmD, CDCES, an endocrine clinical pharmacy specialist in the Endocrine and Metabolism Institute at Cleveland Clinic in Ohio

This has been seen in clinical studies

While GLP-1s are a powerful tool, our focus is on improving your overall metabolic health so youre not dependent long term

Its ability to suppress appetite, slow digestion, and improve insulin sensitivity makes it a comprehensive solution for managing obesity and weight-related health conditions